GLP-3 (Rt)

Retatrutide is a next-generation triple-receptor agonist (GLP-1, GIP, and glucagon) studied intensively in the metabolic category. Research has focused on its potential influence on appetite regulation, blood-sugar control, and body-weight management through simultaneous action on three metabolic pathways. This 5 mg vial is the entry size in our Retatrutide range, popular for starting a study protocol. It is supplied as a lyophilized powder for reconstitution with bacteriostatic water. Offered strictly for laboratory research use only, not for human consumption.